F. Kazerouni, Hoda Zeynalian, F. Ebrahimi, A. Rahimipour, Mostafa Bakhshi, Roghaieh Samadi
{"title":"用脂质过氧化标记评价小鼠食用鸡蛋黄抗体(IgY)的安全性","authors":"F. Kazerouni, Hoda Zeynalian, F. Ebrahimi, A. Rahimipour, Mostafa Bakhshi, Roghaieh Samadi","doi":"10.22037/JPS.V8I3.17032","DOIUrl":null,"url":null,"abstract":"Production of antibodies in chickens (IgY) has significantly attracted attention of scientists. Numerous publications have reported use of IgY in diagnosis, therapy and prophylaxis. Production of antigen-specific antibodies in chicken can help treat and prevent infectious diseases. The aim of this study was to assess the safety of IgY( anti E. coli O157:H7) on the antioxidant system in mice .Therefore in this study, three different doses of IgY against E. coli O157:H7 (0.9375, 1.875 and 3.75 g / kg) were administrated through oral route to 18 mice (treated groups) and PBS to the control group and 14 days after administration, blood samples were collected from the mice. Serum malondialdehyde (MDA) level and catalase, glutathione peroxidase and superoxide dismutase activity were measured using commercial kits. Oral administration of IgY against E. coli O157:H7 in doses of 0.9375, 1.875 and 3.75 g / kg caused no deaths and showed no toxic effects on mice. In this study, after 14 days of IgY administration there were no significant changes in the activity of antioxidant enzymes (catalase, glutathione peroxidase and superoxide dismutase) and MDA serum level compared to the control group. Our findings revealed that oral administration of IgY against E. coli O157:H7 does not show any toxic effects and does not disturb the antioxidant system in mice . These findings could be indicative of safety of oral administration of IgY in mice.","PeriodicalId":16663,"journal":{"name":"Journal of paramedical sciences","volume":"1 1","pages":"29-35"},"PeriodicalIF":0.0000,"publicationDate":"2017-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assessment of the safety of chicken egg yolk antibody (IgY) consumption by lipid peroxidation marker in mice\",\"authors\":\"F. Kazerouni, Hoda Zeynalian, F. Ebrahimi, A. Rahimipour, Mostafa Bakhshi, Roghaieh Samadi\",\"doi\":\"10.22037/JPS.V8I3.17032\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Production of antibodies in chickens (IgY) has significantly attracted attention of scientists. Numerous publications have reported use of IgY in diagnosis, therapy and prophylaxis. Production of antigen-specific antibodies in chicken can help treat and prevent infectious diseases. The aim of this study was to assess the safety of IgY( anti E. coli O157:H7) on the antioxidant system in mice .Therefore in this study, three different doses of IgY against E. coli O157:H7 (0.9375, 1.875 and 3.75 g / kg) were administrated through oral route to 18 mice (treated groups) and PBS to the control group and 14 days after administration, blood samples were collected from the mice. Serum malondialdehyde (MDA) level and catalase, glutathione peroxidase and superoxide dismutase activity were measured using commercial kits. Oral administration of IgY against E. coli O157:H7 in doses of 0.9375, 1.875 and 3.75 g / kg caused no deaths and showed no toxic effects on mice. In this study, after 14 days of IgY administration there were no significant changes in the activity of antioxidant enzymes (catalase, glutathione peroxidase and superoxide dismutase) and MDA serum level compared to the control group. Our findings revealed that oral administration of IgY against E. coli O157:H7 does not show any toxic effects and does not disturb the antioxidant system in mice . These findings could be indicative of safety of oral administration of IgY in mice.\",\"PeriodicalId\":16663,\"journal\":{\"name\":\"Journal of paramedical sciences\",\"volume\":\"1 1\",\"pages\":\"29-35\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of paramedical sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22037/JPS.V8I3.17032\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of paramedical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22037/JPS.V8I3.17032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
鸡体内产生的抗体(IgY)引起了科学家们的极大关注。许多出版物报道了IgY在诊断、治疗和预防中的应用。鸡体内产生抗原特异性抗体有助于治疗和预防传染病。为了研究抗O157:H7大肠杆菌IgY对小鼠抗氧化系统的安全性,本研究采用三种不同剂量的抗O157:H7大肠杆菌IgY(0.9375、1.875和3.75 g / kg)分别口服给药组(18只)和对照组(PBS),给药后14 d采集小鼠血液。测定血清丙二醛(MDA)水平及过氧化氢酶、谷胱甘肽过氧化物酶和超氧化物歧化酶活性。口服剂量分别为0.9375、1.875和3.75 g / kg的IgY抗大肠杆菌O157:H7,未造成小鼠死亡,对小鼠无毒性作用。在本研究中,IgY给药14天后,抗氧化酶(过氧化氢酶、谷胱甘肽过氧化物酶和超氧化物歧化酶)活性和血清丙二醛水平与对照组相比无显著变化。我们的研究结果表明,口服IgY抗大肠杆菌O157:H7没有任何毒性作用,也不会干扰小鼠的抗氧化系统。这些发现可能表明口服IgY小鼠的安全性。
Assessment of the safety of chicken egg yolk antibody (IgY) consumption by lipid peroxidation marker in mice
Production of antibodies in chickens (IgY) has significantly attracted attention of scientists. Numerous publications have reported use of IgY in diagnosis, therapy and prophylaxis. Production of antigen-specific antibodies in chicken can help treat and prevent infectious diseases. The aim of this study was to assess the safety of IgY( anti E. coli O157:H7) on the antioxidant system in mice .Therefore in this study, three different doses of IgY against E. coli O157:H7 (0.9375, 1.875 and 3.75 g / kg) were administrated through oral route to 18 mice (treated groups) and PBS to the control group and 14 days after administration, blood samples were collected from the mice. Serum malondialdehyde (MDA) level and catalase, glutathione peroxidase and superoxide dismutase activity were measured using commercial kits. Oral administration of IgY against E. coli O157:H7 in doses of 0.9375, 1.875 and 3.75 g / kg caused no deaths and showed no toxic effects on mice. In this study, after 14 days of IgY administration there were no significant changes in the activity of antioxidant enzymes (catalase, glutathione peroxidase and superoxide dismutase) and MDA serum level compared to the control group. Our findings revealed that oral administration of IgY against E. coli O157:H7 does not show any toxic effects and does not disturb the antioxidant system in mice . These findings could be indicative of safety of oral administration of IgY in mice.